JennyChan

Associate

New York + 1.212.326.3674

Jenny Chan advises private equity firms and public companies on domestic and cross-border transactions. She has represented clients in a variety of industries, including biotechnology, consumer goods, financial institutions, government contracting, insurance, managed services, media production, and wine and beverage. She also counsels clients on general corporate matters.

Experience

  • Cypress Group sells majority stake to Milestone PartnersJones Day advised Cypress Group Holdings, Inc., a property and casualty insurance holding company with wholly-owned downstream operating entities in Florida, Texas, Louisiana and South Carolina, in the sale of the majority of Cypress and certain affiliated companies to funds managed by Milestone Partners.
  • EagleTree Capital acquires IntegreonJones Day advised EagleTree Capital in connection with the acquisition and financing of Integreon, a leading global managed services provider, from NewQuest Capital Partners.
  • Bespoke Capital Acquisition Corp. combines with Vintage Wine EstatesJones Day advised Bespoke Capital Acquisition Corp., a TSX listed special acquisition company ("BCAC"), on its business combination with Vintage Wine Estates, one of the fastest growing U.S. wine producers.
  • Solmax acquires TenCate GeosyntheticsJones Day advised Groupe Solmax Inc. (Solmax), the global leader in the production of high-quality polyethylene geomembranes for industrial and environmental applications, and its shareholders (including institutional investors Caisse de dépot et placement du Québec and Fonds de Solidarité FTQ), in connection with Solmax’s acquisition of TenCate Geosynthetics Holding B.V., a global provider of geosynthetics and industrial fabrics, from Dutch conglomerate Koninklijke Ten Cate (Royal Ten Cate, the Netherlands), and advised on the related senior secured financing to support the acquisition.
  • Centre Lane Partners sells Perform[cb] to Beringer CapitalJones Day represented Centre Lane Partners, LLC in the sale of preeminent performance marketing company, Perform[cb], to Beringer Capital.
  • Junshi Biosciences collaborates with Coherus Biosciences to co-develop anti-PD-1 antibody and grants options for anti-TIGIT and IL-2 cytokine moleculesJones Day represented Junshi Biosciences in its license out of technology and IP related to an anti-PD-1 antibody known as Toripalimab and options for two other molecules.
  • J.F. Lehman & Company acquires ENTACTJones Day advised long-standing client J.F. Lehman & Company, a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government, and environmental sectors, in the acquisition by an investment affiliate and financing of ENTACT, LLC, a national provider of environmental remediation and geotechnical services.
  • Global systemically important bank (GSIB) conducts risk assessment to determine impact of LIBOR transition on enterprise-wide portfoliosJones Day is advising a GSIB with respect to enterprise-wide portfolios impacted by the LIBOR transition, including conducting portfolio-wide risk impact assessments, analyzing various consumer products, and developing litigation contingency plans.
  • Goldman Sachs and KeyBanc Capital Markets act as lead agents on update to KeyCorp's Medium-Term Note ProgramJones Day represented Goldman Sachs & Co. LLC and KeyBanc Capital Markets Inc., as lead agents, in connection with an update to KeyCorp's Medium-Term Note Program, under which KeyCorp may issue, from time to time, Senior Medium-Term Notes, Series Q and Subordinated Medium-Term Notes, Series R.
  • FuseFx merges with Folks VFXJones Day advised FuseFX, a portfolio company of EagleTree Capital, in the merger of FuseFX with Folks VFX, a high-end, independent visual effects studio headquartered in Montréal with additional studio locations in Toronto and Bogotá, Colombia.
  • KeyBank issues $700 million of Senior Bank NotesJones Day represented KeyBanc Capital Markets Inc. and the other agents, in connection with KeyBank National Association’s ("KeyBank") offering of $700 million aggregate principal amount of 1.250% Senior Bank Notes due March 10, 2023 in a transaction exempt from registration pursuant to Section 3(a)(2) of the Securities Act of 1933.
  • KeyBanc Capital Markets-led syndicate completes $800 million offering of 2.250% Senior NotesJones Day represented KeyBanc Capital Markets Inc., as lead-left book-running manager, together with the other underwriters, in KeyCorp's public offering of $800 million of 2.250% Senior Notes due April 2027 under KeyCorp's Medium-Term Notes Program.
  • Diamond S Shipping completes secondary public offering of Common SharesJones Day represented Diamond S Shipping Inc. in connection with the underwritten secondary offering of 4,021,604 of the Company’s Common Shares by funds affiliated with First Reserve and 660,870 of the Company’s Common Shares by funds affiliated with WL Ross & Co. LLC as the selling shareholders.